Name: UMIN ID:
Unique ID issued by UMIN | UMIN000035533 |
---|---|
Receipt number | R000040483 |
Scientific Title | Fulvestrant and CDK4/6 inhibitor as first line hormonal therapy for locally advanced/ metastatic disease for Patients with Hormone receptor positive HER2 negative breast cancer -observational study |
Date of disclosure of the study information | 2019/01/13 |
Last modified on | 2023/01/29 12:50:37 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2019/01/13 11:41:26 | ||
2 | Update | 2020/08/21 22:12:53 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Address Address Organization Organization Address Address Tel |
|
3 | Update | 2023/01/29 12:50:37 | Date of IRB Last follow-up date |